Press release
Infectious Disease Diagnostics Market to Reach USD 42.20 Billion by 2030 | Rapid Molecular Testing & AI-driven Platforms Lead Growth
Global infectious disease diagnostics market valued at $24.96B in 2024, $26.58B in 2025, and set to hit $40.20B by 2030, growing at 9.7% CAGR.
The global [https://www.marketsandmarkets.com/Market-Reports/infectious-disease-diagnostics-market-116764589.html] is projected to reach USD 42.20 billion by 2030, up from USD 26.58 billion in 2025, growing at a CAGR of 9.7% during the forecast period, according to the latest MarketsandMarkets Trademark report. The market's expansion is fueled by the rising global incidence of infectious diseases, growing demand for early and accurate testing, and technological innovations in molecular diagnostics and point-of-care (PoC) testing.
Market Overview: The Rising Demand for Accurate and Rapid Disease Testing
The growing global burden of infectious diseases-including HIV, tuberculosis, influenza, hepatitis, and healthcare-associated infections (HAIs)-has accelerated the adoption of advanced diagnostic technologies. Recurring outbreaks, such as those caused by novel respiratory viruses, and the emergence of antimicrobial resistance (AMR), have underscored the importance of rapid and precise diagnostic tools.
Key Growth Drivers:
* Increasing global prevalence of infectious and emerging diseases
* Growing focus on early detection and personalized treatment
* Continuous technological advancements in molecular and PoC diagnostics
* Expansion of healthcare infrastructure in developing economies
* Rising government investments in public health surveillance
Together, these factors are driving strong growth across clinical laboratories, hospitals, and research institutions, as healthcare systems prioritize diagnostic accuracy and turnaround speed.
Download PDF: [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=116764589&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]
By Product & Service: Reagents, Kits, and Consumables Dominate the Market
The market is segmented into reagents, kits, and consumables; instruments; and software & services. In 2024, reagents, kits, and consumables accounted for the largest market share and are expected to maintain dominance through 2030.
Why This Segment Leads:
* High testing frequency and recurring demand among end users
* Critical role in ensuring test reliability and sensitivity
* Continuous product innovation in multiplex assays and rapid test kits
* Increasing use of AI-enhanced molecular reagents for faster data interpretation
This recurring revenue stream is vital for diagnostic companies, as consumable purchases represent a stable, long-term growth opportunity.
By Sample Type: Blood, Serum, and Plasma Lead Testing Applications
Based on sample type, the market is segmented into blood, serum, and plasma; urine; and other samples. In 2024, blood, serum, and plasma samples dominated due to their rich diagnostic value and ability to reveal multiple biomarkers and pathogens.
These samples provide comprehensive biological data for PCR, ELISA, NGS, and immunodiagnostic assays, enabling healthcare professionals to:
* Detect infections in early stages
* Monitor disease progression
* Support personalized therapy planning
The continued evolution of liquid biopsy and microfluidic diagnostic platforms is expected to further enhance blood-based testing capabilities.
By Technology: Molecular Diagnostics Driving Accuracy and Speed
The infectious disease diagnostics market is transforming through the adoption of advanced molecular technologies, including:
* Polymerase Chain Reaction (PCR)
* Next-Generation Sequencing (NGS)
* Isothermal Amplification
* Immunodiagnostics (ELISA, rapid antigen tests)
Emerging Trends:
* Miniaturized point-of-care PCR platforms
* Integration of AI-based image and data analysis
* Multi-pathogen syndromic testing panels
* Cloud-enabled diagnostic connectivity for remote healthcare settings
The fusion of molecular diagnostics with digital health technologies enables faster, decentralized testing, improving outbreak management and patient outcomes.
By Region: North America Leads Global Market Share
North America accounted for the largest share of the infectious disease diagnostics market in 2024, supported by:
* Advanced healthcare infrastructure
* High diagnostic testing rates
* Early adoption of AI and automation in laboratories
* Continuous R&D investment by leading diagnostic manufacturers
The United States remains a global innovation hub, driven by FDA approvals, strong public-private partnerships, and government initiatives to strengthen disease surveillance systems.
Meanwhile, the Asia Pacific region is expected to witness the fastest growth, supported by:
* Rapid healthcare modernization in China, India, and South Korea
* Expanding diagnostic access in rural and underserved areas
* Growing focus on infectious disease prevention and control programs
Innovation Spotlight: AI and Point-of-Care Diagnostics Revolutionizing Testing
Emerging technologies are transforming how healthcare providers detect and manage infectious diseases:
* AI-powered diagnostic platforms enhance test interpretation, reducing false negatives and improving clinical decision-making.
* Portable point-of-care devices enable testing in decentralized environments, from clinics to home care.
* Cloud-based connectivity supports real-time data sharing and outbreak monitoring.
* NGS-based pathogen identification facilitates comprehensive surveillance of evolving strains and resistance patterns.
These innovations are central to achieving global health resilience and precision-based public health strategies.
Key Market Players
Leading companies shaping the infectious disease diagnostics landscape include: F. Hoffmann-La Roche Ltd. (Switzerland), Abbott (US), Danaher Corporation (US), bioMerieux (France), Thermo Fisher Scientific Inc. (US), Siemens Healthineers AG (Germany), Becton, Dickinson and Company (US), Hologic, Inc. (US), QIAGEN N.V. (Netherlands), and Bio-Rad Laboratories, Inc. (US).
These companies are investing in AI-enabled diagnostic automation, portable molecular testing, and syndromic panels, driving innovation across clinical and research applications.
Conclusion: Diagnostics at the Core of Global Health Preparedness
As infectious threats evolve, accurate, rapid, and decentralized testing has become essential to global health strategies. The infectious disease diagnostics market is poised for sustained growth, powered by molecular innovations, AI-driven platforms, and expanding diagnostic infrastructure in both developed and emerging economies.
With increasing global health challenges, diagnostics remains the cornerstone of effective disease prevention, timely treatment, and population-level surveillance.
Request Sample Pages: [https://www.marketsandmarkets.com/requestsampleNew.asp?id=116764589&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]
Media Contact
Company Name: MarketsandMarkets Trademark Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=infectious-disease-diagnostics-market-to-reach-usd-4220-billion-by-2030-rapid-molecular-testing-aidriven-platforms-lead-growth]
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/infectious-disease-diagnostics-market-116764589.html
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Infectious Disease Diagnostics Market to Reach USD 42.20 Billion by 2030 | Rapid Molecular Testing & AI-driven Platforms Lead Growth here
News-ID: 4241409 • Views: …
More Releases from ABNewswire
AI Video Analytics Market to Reach $17.24 Bn by 2031, Driven by Smart City Adopt …
Mordor Intelligence has published a new report on the AI Video Analytics Market, offering a comprehensive analysis of trends, growth drivers, and future projections.
AI Video Analytics Market Overview
The AI Video Analytics Market [https://www.mordorintelligence.com/industry-reports/global-ai-video-analytics-market?utm_source=abnewswire] is witnessing steady expansion as organizations adopt data-driven video intelligence to support security, operational monitoring, and customer insight initiatives. According to Mordor Intelligence, the AI Video Analytics Market size was valued at USD 5.04 billion in 2025…
Las Vegas Hard Rock Band Foundry Launches Bold Coffee Line That Matches Their So …
Foundry, a Las Vegas-based hard rock band, has expanded from the stage to the kitchen counter with the launch of their Hard Rock Roast coffee. The coarse-ground coffee features notes of dark chocolate, brown sugar, and rich molasses, designed to fuel late nights and loud mornings for fans and coffee enthusiasts alike.
Most coffee brands start with market research, focus groups, and corporate boardrooms. Foundry started with amplifiers, drum kits, and…
Counselling Birmingham UK: Phinity Therapy Responds to Rising Demand for Marriag …
Phinity Therapy, a trusted provider of psychotherapy and counselling services in Birmingham, UK, is responding to rising demand for marriage and relationship counselling. As searches for counselling near me increase across the city, the practice continues to support individuals and couples seeking professional, accessible counselling services in Birmingham.
Birmingham, UK - As awareness around mental health and emotional wellbeing continues to grow, Birmingham is experiencing a notable rise in demand for…
Architect-Led Design Draws Focus as Sunshine Coast Projects Face Cost Pressures
As construction costs rise and development continues across the Sunshine Coast, architect-led design is drawing increased attention. Industry commentary suggests early design involvement may help manage affordability, reduce planning risk, and limit costly project changes.
SUNSHINE COAST, QLD - January 12, 2026 - Rising construction costs and continued development activity across the Sunshine Coast are changing how residential and commercial projects are being planned. Architects working in the region say early…
More Releases for CAGR
[CAGR of 6.7%] Nanocoatings Market Size, Industry Share, CAGR, Regional Forecast …
The global Nanocoatings Market generated $10.7 billion in 2020, and is projected to reach $20.1 billion by 2030, growing at a CAGR of 6.7% from 2021 to 2030. The report provides an in-depth analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive scenario, and wavering market trends.
Download sample PDF @ https://www.alliedmarketresearch.com/request-sample/2064
According to the report published by Allied Market Research,…
[CAGR of 5.3%] Pigments Market Size, Industry Share, CAGR, Regional Forecast, 20 …
A recent report by Allied Market Research provides a detailed analysis of the pigments market, highlighting its robust growth. The industry was valued at $27.2 billion in 2022 and is projected to surge to $45.4 billion by 2032, exhibiting an impressive CAGR of 5.3% from 2023 to 2032.
This research report identifies the growth drivers behind the market's expansion and delves into the market dynamics using advanced analytical frameworks…
Enzymes Market Expansion CAGR of 4.9% CAGR Anticipated 2025-2034
The Enzymes Market report is an in-depth examination of the global Enzymes Market's general consumption structure, development trends, sales techniques, and top nations' sales. The research looks at well-known providers in the global Enzymes Market industry, as well as market segmentation, competition, and the macroeconomic climate. A complete Enzymes Market analysis takes into account a number of aspects, including a country's population and business cycles, as well as market-specific microeconomic…
Waterproofing Membranes Market is Projected Grow at CAGR of 8% CAGR by 2033
The waterproofing membranes market is anticipated to witness a Compound Annual Growth Rate (CAGR) of 8.0% over the forecast period. By 2023, the estimated market value for waterproofing membranes is substantial, reaching US$ 31.5 billion.
These waterproofing materials comprise thin, impermeable membranes designed to collaborate with asphalt, providing a protective shield for the structural integrity of buildings. The asphalt component in these membranes acts as a safeguard, preserving the underlying membrane…
Electric Bed Market CAGR, Size, Share Grow USD 2,063 Million by 2030 CAGR 13.70%
Global electric bed market size is expected to be worth roughly USD 2,063 million by 2030, growing at a CAGR of more than 13.7% during the projected timeframe of 2022-2030, according to Ameco Research
A significant portion of the population over the age of 60, who often have reduced immunity levels and are more susceptible to neurological disorders, cardiac issues, tumors, and spinal cord compression, is anticipated to have a substantial…
Pediatric Radiology Market Size will Grow at CAGR 7.7% CAGR during 2017-2026
Pediatric Radiology Market:Overview
The pediatric radiology market is likely to register robust growth in the near future. Chronic illnesses among children including neurological disorders such as ADHD are on the rise. According to the US labor bureau, the demand for pediatrician is expected to grow by 24% on average by 2020. This is the highest average growth among all professionals in the United States.
Despite challenges such as training for new…
